Showing 961-970 of 1046 results for "".
- Toku Obtains CE and UKCA Marks for AI Cardiovascular Risk Assessments Through the Eyehttps://modernod.com/news/toku-obtains-ce-and-ukca-marks-for-ai-cardiovascular-risk-assessments-through-the-eye/2482096/Toku announced that it has obtained CE Mark in Europe and UKCA in the United Kingdom for its patented CLAiR technology, which provides a non-invasive evaluation for the risk of cardiovascular disease (CVD) at the point of care using retinal images captured during a routine eye exam
- Orcam Technologies Unveils Orcam Read 3 AI-Driven Solution for People with Low Vision and Visual Impairmentshttps://modernod.com/news/orcam-technologies-unveils-orcam-read-3-ai-driven-solution-for-people-with-low-vision-and-visual-impairments/2481965/OrCam Technologies has introduced the OrCam Read 3, which is designed to improve the way people with vision loss and reading difficulties interact with visual materials. User point the device at a book, computer screen, product packaging or any text, and the AI technology will loudly and cle
- FDA Grants Breakthrough Device Status to Toku’s Patented Cardiovascular Risk AI (CLAiR) Platformhttps://modernod.com/news/fda-grants-breakthrough-device-status-to-tokus-patented-cardiovascular-risk-ai-clair-platform/2481934/Toku announced that the FDA has granted Breakthrough Device designation to its patented CLAiR technology. According to Toku, the CLAiR platform, if cleared by the FDA, will be the first medical device in the US market that can provide affordable, point-of-care and non-invasive
- Sight Sciences Presents Phase 1 Results of the SAHARA Trial Comparing TearCare to Restasis for the Treatment of Dry Eye Diseasehttps://modernod.com/news/sight-sciences-presents-phase-1-results-of-the-sahara-trial-comparing-tearcare-to-restasis-for-the-treatment-of-dry-eye-disease/2481888/Sight Sciences announced the presentation of the full phase 1 results from the SAHARA randomized controlled trial, demonstrating that interventional eyelid procedures for dry eye disease enabled by TearCare technology were superior at all measured time points to Restasis prescription eye dro
- In Final Rule, CMS Rejects Proposal to Make Facility Payments for Office-Based Ophthalmic Surgerieshttps://modernod.com/news/in-final-rule-cms-rejects-proposal-to-make-facility-payments-for-office-based-ophthalmic-surgeries/2481218/In its Medicare Physician Fee Schedule Final Rule for 2023, CMS rejected a proposal to make facility payments for office-based ophthalmic surgeries. The following is a summary of this and other key points in the ruling. Office-based payments. In response to requests to
- Bruder Introduces In-Office Package Options for Moist Heat Eye Compresshttps://modernod.com/news/bruder-introduces-in-office-package-options-for-moist-heat-eye-compress/2480759/Bruder recently introduced two new in-office package options for its moist heat eye compress. A new box and counter display make retail opportunities easier by offering an attractive, small-footprint way to showcase the Bruder Eye Compress in high-traffic, point-of sale locations throughout
- Lensbox Launches 480+ First-to-Market Eye Care Patient Experience Centers in the US and Canadahttps://modernod.com/news/lensbox-launches-480-first-to-market-eyecare-patient-experience-centers-in-the-us-and-canada/2480652/Lensbox has announced the launch of 480+ Lensbox EyeDocs. The "bricks and clicks technology" features fully automated patient experience centers that integrate with the Lensbox first-to-market app, tying in tele-optometry, e-commerce, and point-of-sale technology for
- Vision Health Alliance Launches First Consumer Awareness Campaignhttps://modernod.com/news/vision-health-alliance-launches-first-consumer-awareness-campaign/2479484/Vision Health Alliance, The Vision Council’s new consumer education initiative, announced the launch of its first consumer education movement. The “Let’s Be Clear” campaign debuted last week online across multiple digital and social media channels and features direct, to-the-point me
- US Prepares for Wide Rollout of COVID-19 Boosters Next Monthhttps://modernod.com/news/us-prepares-for-wide-rollout-of-covid-19-boosters-next-month/2479458/US officials announced that health agencies in the country are preparing to widely distribute third doses of mRNA COVID-19 vaccines beginning the week of September 20, citing new data that point to waning protection over time. The move was unveiled in a statement signed by health leaders includin
- Neurolens Announces the Launch of the nMD2 Measurement Devicehttps://modernod.com/news/neurolens-announces-the-launch-of-the-nmd2-measurement-device/2479022/Neurolens has announced the launch of the neurolens Measurement Device, Gen 2 (nMD2), an objective and repeatable way to measure binocular vision, or more specifically, eye alignment. Employing over 10,000 data points per patient, the eye tracking system can identify eye misalignment as small as